The interactive effects of JUUL flavor and nicotine concentration on addiction potential

Prior research suggests that flavors can influence the pharmacological effects of nicotine. We used commercially available JUUL pods to examine whether preferred menthol versus tobacco flavor increased the addictive potential of nicotine per se. This study recruited 15 regular JUUL e-cigarette users to complete a 2 × 2 factorial crossover trial using an entirely remote video format. Participants completed a sampling baseline session to identify preferred JUUL flavor (menthol vs. tobacco) followed by four counterbalanced experimental sessions separated by ≥ 48 hr: (a) low-nicotine dose (3% JUUL)/nonpreferred flavor; (b) low dose/preferred flavor; (c) high-nicotine dose (5% JUUL)/nonpreferred flavor; and (d) high dose/preferred flavor. In each experimental session, participants completed a puffing procedure followed by subjective ratings of e-cigarette liking and wanting (ELW), urges, and reinforcement using a JUUL pod purchase task. There was a dose-by-flavor interaction for average ELW (F = 4.58, p = .041) in which ELW was significantly greater for the preferred than the nonpreferred flavor at the low-nicotine dose but not the high-nicotine dose. There were also dose-by-flavor interactions for pre- to post-puffing change in overall urge to vape (F = 5.97, p = .021) and urge strength (F = 4.96, p = .049), with greater reductions in overall urge/strength for the preferred compared to the nonpreferred flavor at the low but not the high dose. We found no significant interaction effects for purchase task outcomes. Using a fully remote experimental puffing procedure, our findings suggest preferred flavors increase the rewarding effects most for lower nicotine e-cigarettes. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:31

Enthalten in:

Experimental and clinical psychopharmacology - 31(2023), 2 vom: 28. Apr., Seite 336-342

Sprache:

Englisch

Beteiligte Personen:

Peasley-Miklus, Catherine [VerfasserIn]
Klemperer, Elias M [VerfasserIn]
Hughes, John R [VerfasserIn]
Villanti, Andrea C [VerfasserIn]
Krishnan-Sarin, Suchitra [VerfasserIn]
DeSarno, Michael J [VerfasserIn]
Mosca, Letizia A [VerfasserIn]
Su, Alan [VerfasserIn]
Cassidy, Rachel N [VerfasserIn]
Feinstein, Marc Jerome P [VerfasserIn]

Links:

Volltext

Themen:

1490-04-6
6M3C89ZY6R
Clinical Trial
Journal Article
Menthol
Nicotine

Anmerkungen:

Date Completed 28.03.2023

Date Revised 02.04.2024

published: Print-Electronic

ClinicalTrials.gov: NCT04696380

Citation Status MEDLINE

doi:

10.1037/pha0000591

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM345654242